本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Karyopharm Therapeutics Inc.

1.61
-0.0100-0.62%
盤後1.60-0.0096-0.60%19:59 EDT
成交量:673.75萬
成交額:967.02萬
市值:3,648.73萬
市盈率:-0.12
高:1.61
開:1.50
低:1.24
收:1.62
52周最高:10.99
52周最低:1.24
股本:2,266.29萬
流通股本:1,577.42萬
量比:8.47
換手率:42.71%
股息:- -
股息率:- -
每股收益(TTM):-13.0816
每股收益(LYR):-17.9300
淨資產收益率:-891.05%
總資產收益率:-47.61%
市淨率:-0.11
市盈率(LYR):-0.09

資料載入中...

2026/09/11

重要事件披露

Form 8-K - Current report
2026/09/04

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/31

重要事件披露

Form 8-K - Current report
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/13

重要事件披露

Form 8-K - Current report
2026/08/12

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/11

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/31

重要事件披露

Form 8-K - Current report
2026/07/29

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/17

重要事件披露

Form 8-K - Current report
2026/06/05

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/29

重要事件披露

Form 8-K - Current report
2026/05/28

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/05/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]